Mineralys Therapeutics, Inc. (MLYS) — Dilution Risk Analysis
Current Snapshot
Mineralys Therapeutics, Inc. (MLYS) has a DilutionWatch score of 31/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 31/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-04-02 | 0001816952-26-000002 |
| 4 | 2026-04-02 | 0001644975-26-000004 |
| 4 | 2026-03-31 | 0001231919-26-000300 |
| 4 | 2026-03-17 | 0001672659-26-000018 |
| 4 | 2026-03-16 | 0001933414-26-000058 |
| 4 | 2026-03-10 | 0001672659-26-000015 |
| 3 | 2026-03-04 | 0001916048-26-000007 |
| 4 | 2026-02-20 | 0001933414-26-000037 |
| 4 | 2026-02-20 | 0001933414-26-000038 |
| 4 | 2026-02-20 | 0001933414-26-000039 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 14 months | Source |
| Three-year share count growth | 115.08% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 31/10) Source
- Cash Runway
- 14 months Source
- Share Count Growth (3-Year)
- 115.08% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.